SFN played a positive role in cardiomyopathy that was specifically related to the Nrf2-mediated antioxidant pathways (nuclear factor, erythroid 2 like 2) and the AMPK-upregulated lipid metabolism29,42,43. The gene discussed is SFN; the disease is cardiomyopathy.